2003 Meeting Symposia

Selection and Monitoring of Antimicrobial Therapy in Musculoskeletal Infection

Friday, August 1, 2003 2:00 PM -3:30 PM

Doug Osmon MD, MPH and Elie Berbari MD

Musculoskeletal infection is a complicated, difficult problem to treat both from a medical and surgical perspective. Musculoskeletal infection is a frequent source of referral to both infectious disease specialists and orthopedic surgeons. The participants in this symposium will discuss the principles of antimicrobial therapy for different musculoskeletal infection syndromes in adults including chronic osteomyelitis, prosthetic joint infection, vertebral osteomyelitis and diabetic foot infections. At the end of 90 minutes the audience will have received an update on the following topics regarding antimicrobial therapy for musculoskeletal infection.

  1. Pertinent history and physical to guide the selection of empiric antimicrobial therapy for different musculoskeletal infection syndromes.
  2. Important considerations in the collection of specimens for pathologic examination and culture for different musculoskeletal infection syndromes.
  3. Important considerations in the selection of empiric systemic antimicrobial therapy for different musculoskeletal infection syndromes.
  4. Rationale for the selection of microorganism specific antimicrobial therapy for different musculoskeletal infection syndromes. This topic will include data on the use of fluoroquinolones and rifampin for orthopedic hardware associated infection.
  5. Rationale for the selection of a duration of antimicrobial therapy for different musculoskeletal infection syndromes. This topic will include data on the use of fluoroquinolones and rifampin for orthopedic hardware associated infection.
  6. The role of monitoring systemic and local antimicrobial therapy for efficacy and toxicity.